PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Acerta Pharma BV
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center